{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T19:59:28Z","timestamp":1783022368780,"version":"3.54.6"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.taap.2022.115912","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T23:34:14Z","timestamp":1644276854000},"page":"115912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Prediction of the human pharmacokinetics of epyrifenacil and its major metabolite, S-3100-CA, by a physiologically based pharmacokinetic modeling using chimeric mice with humanized liver"],"prefix":"10.1016","volume":"439","author":[{"given":"Kota","family":"Hirasawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Nagahori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Kitamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2022.115912_bb0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.taap.2017.11.028","article-title":"Flumioxazin metabolism in pregnant animals and cell-based protoporphyrinogen IX oxidase (PPO) inhibition assay of fetal metabolites in various animal species to elucidate the mechanism of the rat-specific developmental toxicity","volume":"339","author":"Abe","year":"2018","journal-title":"Tox Appl Pharmacol."},{"key":"10.1016\/j.taap.2022.115912_bb0010","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1021\/acs.jafc.7b05463","article-title":"Identification of metabolism and excretion differences of procymidone between rats and humans using chimeric mice: implications for differential developmental toxicity","volume":"66","author":"Abe","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.taap.2022.115912_bb0015","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.etap.2015.02.011","article-title":"Human biofluid concentrations ofmono(2-ethylhexyl)phthalate extrapolated frompharmacokinetics in chimeric mice withhumanized liver administered with di(2-ethylhexyl)phthalate and physiologicallybased pharmacokinetic modeling","volume":"39","author":"Adachi","year":"2015","journal-title":"Environ Toxicol Phar."},{"key":"10.1016\/j.taap.2022.115912_bb0020","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/10408440600977677","article-title":"IPCS framework for analyzing the relevance of a cancer mode of action for humans","volume":"36","author":"Boobis","year":"2006","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2022.115912_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/10408440701749421","article-title":"IPCS framework for analyzing the relevance of a noncancer mode of action for humans","volume":"38","author":"Boobis","year":"2008","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.taap.2022.115912_bb0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yrtph.2009.08.001","article-title":"Application of toxicokinetics to improve chemical risk assessment: implications for the use of animals","volume":"55","author":"Creton","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2022.115912_bb0035","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.yrtph.2011.12.005","article-title":"Use of toxicokinetics to support chemical evaluation: informing high dose selection and study interpretation","volume":"62","author":"Creton","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.taap.2022.115912_bb0040","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1124\/dmd.107.019026","article-title":"Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes","volume":"36","author":"Fukuda","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2022.115912_bb0045","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/toxsci\/kfq051","article-title":"Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model","volume":"115","author":"Godin","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2022.115912_bb0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/toxsci\/kfj001","article-title":"Mode of action in relevance of rodent liver tumors to human cancer risk","volume":"89","author":"Holsapple","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2022.115912_bb0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40262-013-0097-y","article-title":"A mechanistic framework for in vitro-in vivo extrapolation of liver membrane transporters: prediction of drug-drug interaction between rosuvastatin and cyclosporine","volume":"53","author":"Jamei","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.taap.2022.115912_bb0060","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","article-title":"Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update","volume":"25","author":"Jantratid","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2022.115912_bb0065","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.reprotox.2020.11.007","article-title":"Different effects of an N-phenylimide herbicide on heme biosynthesis between human and rat erythroid cells","volume":"99","author":"Kawamura","year":"2021","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.taap.2022.115912_bb0070","series-title":"PBPK Modelling of Intracellular Drug Delivery through Active and Passive Transport Processes. Intracellular Delivery III. Fundamental Biomedical Technologies","first-page":"363","author":"Kuepfer","year":"2016"},{"key":"10.1016\/j.taap.2022.115912_bb0075","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.xphs.2019.12.009","article-title":"Prediction characteristics of oral absorption simulation software evaluated using structurally diverse low-solubility drugs","volume":"109","author":"Matsumura","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.taap.2022.115912_bb0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1584\/jpestics.D21-026","article-title":"Comparative hepatotoxicity of a herbicide, epyrifenacil, in humans and rodents by comparing the dynamics and kinetics of its causal metabolite","volume":"46","author":"Matsunaga","year":"2021","journal-title":"J. Pestic. Sci."},{"key":"10.1016\/j.taap.2022.115912_bb0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1080\/00498254.2018.1460516","article-title":"Prediction of human pharmacokinetics of typical compounds by a physiologically based method using chimeric mice with humanized liver","volume":"49","author":"Nakayama","year":"2019","journal-title":"Xenobiotica."},{"key":"10.1016\/j.taap.2022.115912_bb0090","first-page":"1316","article-title":"Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans","volume":"10","author":"Naritomi","year":"2001","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2022.115912_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.dmpk.2017.11.001","article-title":"Chimeric mice with humanized liver: application in drug metabolism and pharmacokinetics studies for drug discovery","volume":"33","author":"Naritomi","year":"2018","journal-title":"Drug Metab Pharmacok."},{"key":"10.1016\/j.taap.2022.115912_bb0100","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1124\/dmd.114.057372","article-title":"Hepatic, Intestinal, renal, and plasma hydrolysis of prodrugs in human, cynomolgus monkey, dog, and rat: implications for in vitro-in vivo extrapolation of clearance of prodrugs","volume":"42","author":"Nishimuta","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2022.115912_bb0105","series-title":"OECD guideline for testing of chemicals","article-title":"Partition coefficient (n-octanol\/water): shake flask method. Guideline #107","author":"OECD","year":"1995"},{"key":"10.1016\/j.taap.2022.115912_bb0110","series-title":"Guideline #105., OECD Guideline for Testing of Chemicals","author":"OECD., Water solubility","year":"1995"},{"key":"10.1016\/j.taap.2022.115912_bb0115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/toxsci\/kfm041","article-title":"Humanization of excretory pathway in chimeric mice with humanized liver","volume":"97","author":"Okumura","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2022.115912_bb0120","doi-asserted-by":"crossref","first-page":"13190","DOI":"10.1021\/acs.jafc.1c04167","article-title":"Absorption, Distribution, metabolism, and excretion of a new herbicide, epyrifenacil, in rats","volume":"69","author":"Sakurai","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.taap.2022.115912_bb0125","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.877","article-title":"Identification of the organic anion transporting polypeptides responsible for the hepatic uptake of the major metabolite of epyrifenacil, S-3100-CA, in mice","volume":"9","author":"Sakurai","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.taap.2022.115912_bb0130","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/dmd.111.040923","article-title":"Prediction of in vivo hepatic clearance and half-life of drug candidates in human using chimeric mice with humanized liver","volume":"40","author":"Sanoh","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2022.115912_bb0135","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/00498254.2015.1007112","article-title":"Predictability of plasma concentration-time curves in humans using single-species allometric scaling of chimeric mice with humanized liver","volume":"45","author":"Sanoh","year":"2015","journal-title":"Xenobiotica."},{"key":"10.1016\/j.taap.2022.115912_bb0140","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1080\/00498254.2020.1769229","article-title":"Predictability of human pharmacokinetics of drugs that undergo hepatic organic anion transporting polypeptide (OATP)-mediated transport using single-species allometric scaling in chimeric mice with humanized liver: integration with hepatic drug metabolism","volume":"50","author":"Sanoh","year":"2020","journal-title":"Xenobiotica."},{"key":"10.1016\/j.taap.2022.115912_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tox.2011.02.004","article-title":"Absorption, Distribution, metabolism, and excretion of [1-14C]-perfluorohexanoate ([14C]-PFHx) in rats and mice","volume":"283","author":"Shawn","year":"2011","journal-title":"Toxicology"},{"key":"10.1016\/j.taap.2022.115912_bb0150","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1039\/c8tx00019k","article-title":"The association between chemical-induced porphyria and hepatic cancer","volume":"7","author":"Smith","year":"2018","journal-title":"Toxicol Res."},{"key":"10.1016\/j.taap.2022.115912_bb0155","series-title":"Biopharmaceutics Modeling and Simulations: Theory, Practice, Methods, and Applications","author":"Sugano","year":"2012"},{"key":"10.1016\/j.taap.2022.115912_bb0160","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.taap.2014.03.022","article-title":"Metabolism and physiologically based pharmacokinetic modeling of flumioxazin in pregnant animals","volume":"277","author":"Takaku","year":"2014","journal-title":"Toxicol Appl Pharm."},{"key":"10.1016\/j.taap.2022.115912_bb0165","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s11095-006-0162-4","article-title":"Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test","volume":"23","author":"Takano","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2022.115912_bb0170","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1007\/s11095-008-9637-9","article-title":"Rate-limiting steps of oral absorption for poorly water-soluble drugs in dogs; prediction from a miniscale dissolution test and a physiologically-based computer simulation","volume":"25","author":"Takano","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.taap.2022.115912_bb0175","first-page":"510","article-title":"Regional differences in the components of luminal water from rat gastrointestinal tract and comparison with other species","volume":"15","author":"Tanaka","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.taap.2022.115912_bb0180","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10928-011-9200-x","article-title":"Development of appropriate equations for physiologically based pharmacokinetic modeling of permeability-limitd and flow-limited transport","volume":"38","author":"Thompson","year":"2011","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.taap.2022.115912_bb0185","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1584\/jpestics.D17-085","article-title":"Lack of human relevance for procymidone\u2019s developmental toxicity attributable to species difference in its kinetics and metabolism","volume":"43","author":"Tomigahara","year":"2018","journal-title":"J. Pestic. Sci."},{"key":"10.1016\/j.taap.2022.115912_bb0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0378-5173(98)00400-1","article-title":"Gastrointestinal transit of pellets in rats: effect of size and density","volume":"180","author":"Tuleu","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.taap.2022.115912_bb0195","series-title":"Product Properties Test Guidelines","article-title":"OCSPP 830.7550 partition coefficient (n-octanol\/water), shake flask method","author":"U.S. EPA","year":"1996"},{"key":"10.1016\/j.taap.2022.115912_bb0200","series-title":"Product Properties Test Guidelines 712\u2013C\u201398\u2013041","first-page":"1","article-title":"OCSPP 830.7840. Water solubility: column elution method, shake flask method","author":"U.S. EPA","year":"1998"},{"key":"10.1016\/j.taap.2022.115912_bb0205","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1021\/jm070375w","article-title":"High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery","volume":"50","author":"Wan","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.taap.2022.115912_bb0210","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1124\/jpet.108.146647","article-title":"Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans","volume":"328","author":"Watanabe","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2022.115912_bb0215","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jps.20059","article-title":"Computational prediction of the plasma protein-binding percent of diverse pharmaceutical compounds","volume":"93","author":"Yamazaki","year":"2004","journal-title":"J. Pharm. Sci."},{"issue":"S-1","key":"10.1016\/j.taap.2022.115912_bb0220","first-page":"182","article-title":"Pharmacokinetic studies of telithromycin in mouse, rat and dog","volume":"51","author":"Yamazaki","year":"2003","journal-title":"Jpn. J. Chemother."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22000576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X22000576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:57:34Z","timestamp":1758574654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X22000576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":44,"alternative-id":["S0041008X22000576"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2022.115912","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of the human pharmacokinetics of epyrifenacil and its major metabolite, S-3100-CA, by a physiologically based pharmacokinetic modeling using chimeric mice with humanized liver","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2022.115912","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"115912"}}